Conference abstract
Conference abstractPublished 17 Aug 2015
Silicon nanochannel platforms for tightly controlled therapeutic release and immunoisolated cell transplantation
Houston Methodist Research Institute, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Silicon nanochannel platforms leveraging nano-constrained diffusion for tightly controlled therapeutic release and immunoisolated cell transplantation: Through cutting-edge implementation of fabrication techniques developed in the microelectronics industry, our group is able to create dense arrays of nanochannels ranging from nanometers to millimeters in height with a precision of ±10%. Two device platforms have been invented in order to leverage these capabilities: a silicon nanochannel membrane for drug delivery and a surface-modified polymer system for cell transplantation. The drug delivery system employs adaptable channel sizes down to 2.5 nm to closely constrain molecular transport, linearizing Fickian diffusion to achieve constant administration. Implantable drug delivery devices are fashioned by integrating these nanochannel membranes within bioinert metallic or polymeric capsules. These devices are minimally-invasive, can be implanted subcutaneously, and provide linear (zero-order) release of drugs and biomolecules. Clinically-relevant dosages of testosterone for hormone replacement have been released for more than 6 months at a constant rate with this platform. Further innovations include active, on-board control systems to permit remote manipulation or activation, enabling telemedicine or chronotherapy regimens. The polymeric cell transplantation system was primarily developed for pancreatic islet allografts. This device, the “NanoGland”, is used to provide an immunoprotective environment for bioactive allografts by isolating cells from inflammation and rejection mechanisms while permitting interaction with glucose, insulin, nutrients, and waste exchange from the interstitial environment. Combining the NanoGland with the silicon nanochannel membranes has allowed controlled release of immunosuppressive material or factors for cell growth and vascularization following cell transplantation.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Jul 2016
The therapeutic potential of Treg cells in preserving microvascular health in a mouse model of orthotopic tracheal transplantation
Conference abstract · 16 Nov 2015
Innovative Bio MEMS devices leveraging nano-fluidic control for drug delivery and cell transplantation
Conference abstract
Multifunctional mesoporous silicon nanoparticles modified with dieckol/graphene oxide bi-layers for PH/NIR-controlled drug release and remarkable targeting anticancer mitochondria
Editorial · 29 Dec 2025
Sustained and Controlled Release Formulations: Enhancing Therapeutic Efficacy and Patient Compliance
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectImmunology & Microbiology
- SubjectNanotechnology
- SubjectSurgery
- BylineArticles whose byline prints “Alessandro Grattoni”
